Objectives: To evaluate the efficacy and safety of transarterial chemoembolization (TACE)
for recurrent hepatocellular carcinoma (HCC) after curative resection and to examine the …

Abstract Background and Objectives The role of transarterial chemoembolization (TACE) for
inoperable hepatocellular carcinoma (HCC) has remained controversial, and its efficacy for …

OBJECTIVE. The long-term prognosis after hepatic resection for the treatment of
hepatocellular carcinoma (HCC) has been disappointing because of the high recurrence …

Hepatocellular carcinoma (HCC) is one of the most common types of cancer worldwide. only
a minority of HCC patients benefit from curative therapies, such as surgical resection, liver …

The effects of preoperative transcatheter arterial chemoembolization (TACE) were
retrospectively evaluated in patients with resectable hepatocellular carcinoma (HCC). A total …

Hypothesis Transarterial chemoembolization (TACE) is beneficial for selected patients with
unresectable hepatocellular carcinoma (HCC). Design and Setting A prospective …

The long-term survival benefit of treating unresectable hepatocellular carcinoma (HCC)
patients with transarterial chemoembolization (TACE) rather than conservative treatment …

AIM: To prospectively evaluate the short and long term clinical impact of selective
transarterial chemoembolization (TACE) on liver function in patients with hepatocellular …

Objectives Repeat transarterial chemoembolization (TACE) is a common intervention
performed for hepatocellular carcinoma (HCC). The aim of this study was to identify …

BACKGROUND: Transarterial chemoembolization (TACE) is the mainstay of management
for patients with hepatocellular carcinoma who are not suitable for curative treatments …